Page 59
allied
academies
J u n e 2 8 - 2 9 , 2 0 1 8 | A m s t e r d a m , N e t h e r l a n d s
Joint Event on
OBESITY AND WEIGHT MANAGEMENT
VACCINES AND IMMUNOLOGY
&
International Conference on
International Conference on
Asian Journal of Biomedical and Pharmaceutical Sciences
|
Volume 8
ISSN:
2249-622X
IMMUNOLOGICAL ASPECTS OF SUBLINGUAL AND
SUBCUTANEOUS ALLERGEN-SPECIFIC IMMUNOTHERAPY
Nerin Nadir Bahceciler Onder
Near East University, Cyprus
A
lthough, allergen specific sublingual (SL) and subcutaneous immunotherapy (SCIT) have been demonstrated to be clinically
efficient with similar immunological responses, head to head studies comparing those two modes of allergen administration
in terms of onset of clinical improvement along with simultaneous immunological responses and underlying mechanisms of
preventive effect is scarce. Compared to SLIT, SCIT provides a rapid onset of clinical improvement by eliciting a simultaneous
surge in production of Th1 and Treg cytokines and blocking antibodies. Similar immunological and clinical responses are evoked
quite later, with no effect on IgG4 levels during SLIT. Increases in TGF-beta secretion due to non-relevant allegens during SLIT may
explain the preventive effect on new sensitizations. SLIT and SCIT are both clinically efficient in the treatment of respiratory allergic
diseases with slight differences in the early phase in terms of onset of clinical efficacy and simultaneous immunological responses.
Both SLIT and SCIT induce similar T cell responses with different dynamics, but specific IgG4 blocking antibody responses are more
prevelant following SCIT. Further studies addressing the efficacy and immunological responses multiallergen IT in polysensitized
patients are warranted. Updated scientific data on immunological and clinical tolerance of SLIT vs. SCIT will be presented.
nerin74@gmail.comAsian J Biomed Pharmaceut Sci 2018, Volume 8 | DOI: 10.4066/2249-622X-C1-003